Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
OwnerJames T. Dalton, Duane D. Miller +3inventors
InventorsJames T. Dalton, Duane D. Miller, Igor Rakov, Casey Bohl, Michael L. Mohler
Life of this patent
Estimating the term…
Abstract
This invention provides new compounds and uses thereof in treating a variety of diseases or conditions in a subject, including, inter alia, prostate cancer, muscle wasting diseases and/or disorders or a bone-related diseases and/or disorders.
Claims144
A compound represented by the structure of formula I:
- wherein
- X is C or N;
- W is C or N;
- X1 is N, NH, N(C1-4alkyl), NAc, NCOOH, or a bond;
- or X1 and X3 together with X2 and X5 to which X1 and X3 are attached, form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring;
- or X1 and X5 together with X2 to which X1 and X5 are attached form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing;
- P is H or formula II:
- X2 is C1-4alkylne, SO2, C(O), CH—[CH2—C4-8ring)], CH(C1-4 alkyl), CH(NH2), CH(OH), CH(C1-4haloalkyl), a bond;
- or X2 and R3 together with X1, to which X2 is attached, form a ring, which is a saturated or unsaturated, substituted or unsubstituted 5 or 6 membered ring;
- or X2 and X5 form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing,
- X3 is Cl1-4alkylene, NH, N, CH(OH), a bond, or X3 and X1 together with X2 and X5 to which X1 and X3 are attached form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring;
- or X3 and X5 form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing;
- or X3 and X4 form together a double bond or form together a saturated or unsaturated, substituted or unsubstituted 3 to 6 membered ring.
- X4 is O, S, SO, C(O), S(O)[═CHCH2N(CH3)]3 SO2, NH, NHR′, NO, C1-4alkylene, C(OH)[CH2CH2N(CH3)2], C[═CHCH2N(CH3)2], PO(C1-4alkyl), N[CH2CH2N(CH3)2], NO[CH2CH2N(CH3)2] or a bond;
- or X4 and X5 together with X3, to which X4 and X5 are attached form a saturated or unsaturated membered, substituted or unsubstituted 5- or 6-membered ring and A is nothing;
- or X3 and X4 form together a double bond or form together a saturated or unsaturated, substituted or unsubstituted 3 to 6 membered ring.
- X5 is a carbon or X5 and X1 together with X2 to which X1 and X5 are attached form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing;
- or X3 and X2 form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing;
- or X5 and 3 form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing;
- or X5 and X4 together with X3, to which X5 and X4 are attached form a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring and A is nothing,
- A is nothing, H, OH, SH, NH2, C1-4alkyl, CHF2, CH2F, CF3, CN, CH2OH, CH2O(C1-4alkyl), CH2O(C1-4acyl), CH2CN, CH2N3, CH2NCS, CHO, C(O)O(C1-4alkyl), CONHR′, C(O)N(R′)2, C(O)O(C1-4 alkyl), C(O)R′, CH2CF3, CF2CF3, CH2OR′CH2C(O)CH7═CH2 or C(O)CH═CH2;
- or A with R forms a double bond represented by formula III:
- Z is H, CN, NO2, NHC(O)CH3, C1-4alkyl, F, Cl, I or Br;
- Y is H, C1-4alkyl, CF3, NO2, CN, F, Cl, I or Br;
- Q is H, CN, OH, NO2, halide, CF, C2-6alkenyl, C2-6-alkynyl, C(O)CH2NH2, C(O)NH(C1-4alkyl), C(O)N(C1-4alkyl), C(O)NH2, NH(C1-4alkyl), NHC(O)NH(C1-4alkyl), CH2C(O)NH2, NHC(O)NH2, NHCO(C1-4alkyl), NHSO2(C1-4alkyl), O—[CH2CH2CH(CH3)2], O—[CH2CH2(C1-4-cycloalkyl)], O—[CH2CH2(C4-8heterocycloalkyl)] or O—[CH2CH2N(CH3)2];
- R is H, OH, C1-4alkyl, CF3, CH2OH, O(C1-4alkyl) or O(C1-4acyl);
- R1 is H, OH, NH2, F, Cl, Br or I;
- R2 is H, benzyl substituted with R6, (CH2)2—O-p-cyanophenyl, CH2—O-p-cyanophenyl, or CH═CH—O-p-cyanophenyl;
- R3 is H, C1-4alkyl, halide, CN, NO2;
- or R3 and X2 together with the benzene ring to which R3 is attached and X1 to which X2 is attached form a ring, which is a saturated or unsaturated, substituted or unsubstituted 5- or 6-membered ring;
- R′ is NH2, OH or CH3;
- R4 and R5 are independently H, CH3, halide, OH, C1-4alkyl, C1-6cycloalkyl, halo(C1-4alkyl), phenyl, aryl, C4-8heterocycloalkyl, or hydroxy(C1-4alkyl);
- R6 is CN, NO2, NHC(O)CH3 or halide;
- wherein
- if P is formula II, X is C, X1 is NH, X2 is C(O), X3 is CH2, R is OH and A is alkyl or haloalkyl, then X4 is S(O)[═CHCH2N(CH3)2], C(OH)[CH2CH2N(CH3)2], C[═CHCH2N(CH3)2], N[CH2CH2N(CH3)2], P(O)(C1-4alkyl) or N(O)[CH2CH2N(CH3)2];
- or
- if P is formula II, X is C, X1 is NH, X2 is C(O), X3 is CH2, R is OH or OAlk and X4 is O, S, NH, S, SO, SO2 or alkylene, then A is CN, CH2OH, CH2O(C1-4alkyl), CH2O(C1-4acyl), CH2CN, CH2N3, C1-2NCS, CHO, C(O)O(C1-4alkyl), CONHR′, C(O)N(R′)2, C(O)O(C1-4 alkyl), C(O)R′, CH2OR′CH2C(O)CH═CH2 or C(O)CH—CH2;
- or
- if P is phenyl, X is C, X1 is NH, X2 is C(O), R is OH and A is COOH, X3 is a bond, X4 is CH2, R1, R2 are H then Q is not H,
- or
- if P is formula II, X is C, X3 is CH2, X4 is O, or NH, R1, R2 and R3 are H, and X5 and X1 forms a 5 membered ring, an oxazolidine-2-one then Q is not halogen, or H;
- or
- if P is H, X is C, X1 is NH, X2 is C(O), R is OH, A is alkyl, X3 is a bond or CH2 and X4 is bond or CH2, R1 and R2 are H, then Q is not H or halogen.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.